The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: A need for reappraisal, Virus Research, vol.143, issue.2, pp.209-230, 2009. ,
DOI : 10.1016/j.virusres.2009.07.005
Cellular Responses to Viral Infection in Humans: Lessons from Epstein-Barr Virus, Annual Review of Immunology, vol.25, issue.1, pp.587-617, 2007. ,
DOI : 10.1146/annurev.immunol.25.022106.141553
Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorders: Pathogenetic Insights for Targeted Therapy, American Journal of Transplantation, vol.13, issue.Pt 1, pp.888-95, 2011. ,
DOI : 10.2174/092986706778521959
Immune Surveillance and Therapy of Lymphomas Driven by Epstein-Barr Virus Protein LMP1 in a Mouse Model, Cell, vol.148, issue.4, pp.739-51, 2012. ,
DOI : 10.1016/j.cell.2011.12.031
Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agents, Leukemia, vol.104, issue.Part 1, pp.1666-72, 2006. ,
DOI : 10.1182/blood-2004-05-1755
EBV-related disease following haematopoietic stem cell transplantation with reduced intensity conditioning, Leukemia & Lymphoma, vol.30, issue.2, pp.256-69, 2007. ,
DOI : 10.1046/j.1365-2141.2002.03992.x
Delay in B-lymphocyte recovery and function following rituximab for EBV-associated lymphoproliferative disease early post-allogeneic hematopoietic SCT, Bone Marrow Transplantation, vol.77, issue.9, pp.679-84, 2009. ,
DOI : 10.2169/internalmedicine.33.303
Incidence and risk factors of EBV reactivation after unrelated cord blood transplantation: a Eurocord and Soci??t?? Fran??aise de Greffe de Moelle-Therapie Cellulaire collaborative study, Bone Marrow Transplantation, vol.94, issue.2, pp.253-259, 2013. ,
DOI : 10.1016/j.bbmt.2008.05.006
Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning, Transfusion and Apheresis Science, vol.44, issue.2, pp.205-215, 2011. ,
DOI : 10.1016/j.transci.2011.01.019
Routine use of duplex real-time PCR assays including a commercial internal control for molecular diagnosis of opportunistic DNA virus infections, Journal of Virological Methods, vol.185, issue.1, pp.136-177, 2012. ,
DOI : 10.1016/j.jviromet.2012.05.031
A Prospective Study on Modulation of Immunosuppression for Epstein-Barr Virus Reactivation in Pediatric Patients Who Underwent Unrelated Hematopoietic Stem-Cell Transplantation, Transplantation, vol.89, issue.12, pp.1533-1573, 2010. ,
DOI : 10.1097/TP.0b013e3181dd6c0a
Monitoring and Preemptive Rituximab Therapy for Epstein-Barr Virus Reactivation after Antithymocyte Globulin Containing Nonmyeloablative Conditioning for Umbilical Cord Blood Transplantation, Biology of Blood and Marrow Transplantation, vol.16, issue.2, pp.287-91, 2010. ,
DOI : 10.1016/j.bbmt.2009.10.008
Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation, Leukemia, vol.95, issue.6, pp.932-940, 2011. ,
DOI : 10.1038/sj.bmt.1704442
Relationship between NK cell activation and clinical response in rheumatoid arthritis treated with rituximab, Int J Biomed Sci, vol.5, pp.92-97, 2009. ,
Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphism, Blood, vol.10, issue.1, pp.3347-3356, 2011. ,
DOI : 10.1158/1535-7163.MCT-10-0385
Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function, Blood, vol.127, issue.2, pp.2665-74, 2012. ,
DOI : 10.1016/j.imlet.2009.09.009
Epstein???Barr virus, rapamycin, and host immune responses, Current Opinion in Organ Transplantation, vol.13, issue.6, pp.563-571, 2008. ,
DOI : 10.1097/MOT.0b013e3283186ba9
Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients, Leukemia & Lymphoma, vol.73, issue.6, pp.1028-1069, 2008. ,
DOI : 10.1111/j.1600-065X.1997.tb00983.x
Exploiting the Interplay between Innate and Adaptive Immunity to Improve Immunotherapeutic Strategies for Epstein-Barr-Virus-Driven Disorders, Clinical and Developmental Immunology, vol.117, issue.23, pp.1-19, 2012. ,
DOI : 10.1128/JVI.00923-10
Biology and clinical effects of natural killer cells in allogeneic transplantation, Current Opinion in Oncology, vol.22, issue.2, pp.130-137, 2010. ,
DOI : 10.1097/CCO.0b013e328335a559
The biology of human natural killer-cell subsets, Trends in Immunology, vol.22, issue.11, pp.633-673, 2001. ,
DOI : 10.1016/S1471-4906(01)02060-9
CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity, Blood, vol.2, issue.10, pp.3052-3059, 2003. ,
DOI : 10.1038/ni1001-917
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer, Blood, vol.105, issue.8, pp.3051-3058, 2005. ,
DOI : 10.1182/blood-2004-07-2974
Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells, Cytotherapy, vol.11, issue.3, pp.341-55, 2009. ,
DOI : 10.1080/14653240902807034
ERK5 Knockdown Generates Mouse Leukemia Cells with Low MHC Class I Levels That Activate NK Cells and Block Tumorigenesis, The Journal of Immunology, vol.182, issue.6, pp.3398-405, 2009. ,
DOI : 10.4049/jimmunol.0803006
URL : https://hal.archives-ouvertes.fr/hal-02194092
Human Cytomegalovirus Encodes an MHC Class I-Like Molecule (UL142) That Functions to Inhibit NK Cell Lysis, The Journal of Immunology, vol.175, issue.11, pp.7457-65, 2005. ,
DOI : 10.4049/jimmunol.175.11.7457
Virus-mediated inhibition of natural cytotoxicity receptor recognition, Cellular and Molecular Life Sciences, vol.9, issue.2, pp.3911-3931, 2012. ,
DOI : 10.1016/j.chom.2011.01.008
Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model, Haematologica, vol.97, issue.7, pp.1020-1028, 2012. ,
DOI : 10.3324/haematol.2011.054254
Activation of Cytotoxic and Regulatory Functions of NK Cells by Sindbis Viral Vectors, PLoS ONE, vol.16, issue.6, 2011. ,
DOI : 10.1371/journal.pone.0020598.s003
Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity, Blood, vol.101, issue.2, pp.407-421, 2003. ,
DOI : 10.1182/blood-2002-03-0993
NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia, Journal of Clinical Oncology, vol.28, issue.6, pp.995-1004, 2010. ,
DOI : 10.1200/JCO.2009.24.4590